Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
Tran PT, Dat NT, Dang NH, Van Cuong P, Lee S, Hwangbo C, Van Minh C, Lee JH.
Tran PT, et al.
Phytomedicine. 2019 Mar 1;55:1-8. doi: 10.1016/j.phymed.2018.10.029. Epub 2018 Oct 25.
Phytomedicine. 2019.
PMID: 30668419
BACKGROUND: Many bone-related diseases such as osteoporosis and rheumatoid arthritis are commonly associated with excessive activity of the osteoclast. Ganomycin I (GMI), a meroterpenoid isolated from Vietnamese mushroom Ganoderma lucidum, possesses a variety …
BACKGROUND: Many bone-related diseases such as osteoporosis and rheumatoid arthritis are commonly associated with excessive ac …